Charles J. Casamento
At a glance: Charles J. Casamento is Director at Eton Pharmaceuticals (ETON). Their latest SEC Form 4, filed Nov 10, 2026, reported a sale of $410K. On file: 0 purchase lines ($0) and 5 sale lines ($5.3M).
Director at Eton Pharmaceuticals, Inc. (ETON)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Every purchase since 2024
From the SEC's insider data sets: each open-market buy by Charles J. Casamento, matched to how the stock did over the next 90 days against the S&P 500.
0 of 1 buy beat the S&P 500 (0%), median -93.5% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| RLMD | Sep 11, 2024 | -93.5% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 10SEC | ETONEton Pharmaceuticals, Inc. | Sell | 6,38074,175 held (−8%) | $64.33 | $410K | -0.6% |
| Nov 10SEC | ETONEton Pharmaceuticals, Inc. | Sell | 14,71559,460 held (−20%) | $65.32 | $961K | -2.1% |
| Nov 10SEC | ETONEton Pharmaceuticals, Inc. | Sell | 22,60136,859 held (−38%) | $66.26 | $1.5M | -3.5% |
| Nov 10SEC | ETONEton Pharmaceuticals, Inc. | Sell | 33,9562,903 held (−92%) | $67.11 | $2.3M | -4.7% |
| Nov 10SEC | ETONEton Pharmaceuticals, Inc. | Sell | 2,903 | $67.87 | $197K | -5.8% |
- Sell
Director Charles J Casamento sold $1.5M of ETON at $66.26 — cuts the stake by 38%.
- Sell
Director Charles J Casamento sold $2.3M of ETON at $67.11 — cuts the stake by 92%.
Follow Charles J. Casamento
Get one email when Charles J. Casamento files a new purchase or sale. Free.
At most one email a day about Charles J. Casamento, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.